Mintz Levin Represents Myriad Genetics in Acquisition of Assurex Health

09.08.2016 - San Francisco, CA

Attorneys from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented Myriad Genetics, Inc. in its acquisition of Assurex Health.

Myriad Genetics, a global leader in personalized medicine, completed its acquisition of Assurex Health, effective August 31, 2016. Assurex Health is an informatics-based precision medicine company providing treatment decision support to healthcare providers for mental health patients.

To fund the transaction, Myriad entered into a credit agreement with JP Morgan Chase Bank for an aggregate principal amount of $200 million.

Leading the transaction on behalf of Myriad was Robert E. Burwell, Member of Mintz Levin’s Private Equity and Mergers and Acquisition Practices. The Mintz Levin team also included Jonathan L. Kravetz, Chair of the Securities & Capital Markets Practice Group; Minhaj Rahman, Attorney in the Corporate & Securities Practice; Pamela B. Greene, Joseph W. Price, and Julia M. Siripurapu, Members of the Corporate & Securities Practice; David R. Lagasse, Member of the Employment, Labor & Benefits Practice; Karen S. Lovitch, Practice Leader of the firm’s Health Law Practice; Dianne J. Bourque, Member of the Health Law Practice; and Avi Reshtick, Member of the Tax Practice.

Posted in: Press Releases
Actions: E-mail | Permalink |